10 K: a large‐scale prospective longitudinal study in Israel
Authors:
- 15 May 2021
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 36 (11) , 1187-1194
Abstract
The 10 K is a large-scale prospective longitudinal cohort and biobank that was established in Israel. The primary aims of the study include development of prediction models for disease onset and progression and identification of novel molecular markers with a diagnostic, prognostic and therapeutic value. The recruitment was initiated in 2018 and is expected to complete in 2021. Between 28/01/2019 and 13/12/2020, 4,629 from the expected 10,000 participants were recruited (46 %). Follow-up visits are scheduled every year for a total of 25 years. The cohort includes individuals between the ages of 40 and 70 years. Predefined medical conditions were determined as exclusions. Information collected at baseline includes medical history, lifestyle and nutritional habits, vital signs, anthropometrics, blood tests results, Electrocardiography, Ankle–brachial pressure index (ABI), liver US and Dual-energy X-ray absorptiometry (DXA) tests. Molecular profiling includes transcriptome, proteome, gut and oral microbiome, metabolome and immune system profiling. Continuous measurements include glucose levels using a continuous glucose monitoring device for 2 weeks and sleep monitoring by a home sleep apnea test device for 3 nights. Blood and stool samples are collected and stored at − 80 °C in a storage facility for future research. Linkage is being established with national disease registries.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.American Journal of Epidemiology, 2016
- Biobanks in the era of personalized medicine: objectives, challenges, and innovationEPMA Journal, 2015
- Personalized Nutrition by Prediction of Glycemic ResponsesCell, 2015
- The UK Biobank and selection biasThe Lancet, 2012
- The Impact of the Gut Microbiota on Human Health: An Integrative ViewCell, 2012
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyThe Lancet, 2009
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiologyStatistics in Medicine, 2008
- Expansion Sphincter Pharyngoplasty: A New Technique for the Treatment of Obstructive Sleep ApneaOtolaryngology–Head and Neck Surgery, 2007
- Estimating causal effects from epidemiological dataJournal of Epidemiology and Community Health, 2006
- Mediterranean Diet, Lifestyle Factors, and 10-Year Mortality in Elderly European Men and WomenJAMA, 2004